Similar articles

• Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.

  Araya CE, Lew JF, Fennell RS 3rd, Neiberger RE, Dharnidharka VR. Araya CE, et al. Pediatr Transplant. 2006 Feb;10(1):32-7. doi: 10.1111/j.1399-3046.2005.00391.x. Pediatr Transplant. 2006. PMID: 16499584
• BK transplant nephropathy successfully treated with cidofovir.

  Keller LS, Peh CA, Nolan J, Bannister KM, Clarkson AR, Faull RJ. Keller LS, et al. Nephrol Dial Transplant. 2003 May;18(5):1013-4. doi: 10.1093/ndt/gfg061. Nephrol Dial Transplant. 2003. PMID: 12686681 No abstract available.
• A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.

  Kuypers DR, Bammens B, Claes K, Evenepoel P, Lerut E, Vanrenterghem Y. Kuypers DR, et al. J Antimicrob Chemother. 2009 Feb;63(2):417-9. doi: 10.1093/jac/dkn495. Epub 2008 Dec 4. J Antimicrob Chemother. 2009. PMID: 19056749 No abstract available.
• [Therapeutic possibilities for polyomavirus infections in renal transplantation].

  Hurault de Ligny B, Godin M, Lobbedez T, Etienne I, El Haggan W, Pujo M, Ryckelynck JP. Hurault de Ligny B, et al. Presse Med. 2003 Apr 12;32(14):667-8. Presse Med. 2003. PMID: 12714908 Review. French.
• BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality.

  Chittick P, Williamson JC, Ohl CA. Chittick P, et al. Ann Pharmacother. 2013 Sep;47(9):1229-33. doi: 10.1177/1060028013500646. Ann Pharmacother. 2013. PMID: 24259742 Review.